Cumberland Pharmaceuticals
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Cumberland Pharmaceuticals sits in the top decile of US sponsors by registered trial count (#415 of 15,742 sponsors by registered trial count).
Cumberland Pharmaceuticals: 43 sponsored US clinical trials, 1 recruiting.
Cumberland Pharmaceuticals sponsors 43 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 37 completed. 23 of these trials are in Phase 3-4 (later-stage) and 19 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hyponatremia, with 3 trials.
Top-decile sponsor footprint
Cumberland Pharmaceuticals ranks in the top decile of sponsors by registered trial count (#415 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
37 of 41 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
43 total, page 1 of 1
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
NCT05571059
Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
NCT02682511
Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy
NCT03340675
Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic Patients
NCT03611010
Safety and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients
NCT02583399
Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD)
NCT03028350
Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients
NCT02802228
Telavancin Pediatric PK Study (Ages >12 Months to 17 Years)
NCT02013141
A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial
NCT02208063
Telavancin Observational Use Registry (TOUR)
NCT02288234
Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease
NCT02216357
Efficacy and Safety of Bisacodyl and Lactulose as a Preparation for Colonoscopy
NCT02123017
2 Regimens of Lactulose for Colonoscopy Preparation in Adults
NCT01887470
Efficacy of Intravenous Ibuprofen Compared to Intravenous Ketorolac for Pain Control Following Arthroscopic Knee Surgery
NCT01901393
A Pilot Study to Determine the Efficacy of Intravenous Ibuprofen for Pain Control Following Arthroscopic Knee Surgery
NCT01650519
A Study to Assess the Efficacy, Safety and Pharmacokinetics of Intravenous Conivaptan (Vaprisol®) in Pediatric Subjects With Euvolemic or Hypervolemic Hyponatremia
NCT01451411
Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients
NCT01436500
Safety and Efficacy of Intravenous Ibuprofen for Treatment of Pain in Pediatric Patients Undergoing Tonsillectomy
NCT01332253
Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen
NCT01334944
Surgical Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen
NCT01334957
A Study to Assess the Effect of Severe Hepatic Impairment on the Pharmacokinetics of Intravenous Conivaptan
NCT01370148
A Study to Evaluate the Effect of Renal Function on the Biological Activity of Telavancin
NCT01238796
Safety and Efficacy Study of a New Formulation of Acetylcysteine Injection
NCT01118663
Safety, Efficacy, and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients
NCT01002573
A Preference Study Comparing Kristalose® and Liquid Lactulose
NCT00712543
Study to Compare Conivaptan Pharmacokinetics in Subjects With Mild & Moderate Kidney Function Impairment to Subjects With Normal Kidney Function
NCT00887627
Study to Compare Conivaptan in Subjects With Mild & Moderate Liver Impairment Versus Subjects With Normal Liver Function
NCT00851227
Efficacy and Safety Study of Caldolor (Intravenous Ibuprofen) in Hospitalized Adult and Pediatric Burn Patients
NCT00606489
Efficacy and Safety Study of Caldolor (IV Ibuprofen) in Hospitalized Adult Orthopedic Patients
NCT00470600
Study of Efficacy & Safety for 3 Infusion Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia
NCT00478192
A Study of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia
NCT00435591
A Study of Caldolor in Hospitalized Febrile Pediatric Patients
NCT00225706
Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus
NCT00107978
Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus
NCT00107952
Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus
NCT00091819
Trial of Caldolor for Treatment of Pain in Post-Operative Adult Patients
NCT00225732
An Open-Label Study of YM087 (Conivaptan) in Patients With Euvolemic or Hypervolemic Hyponatremia
NCT00379847
Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)
NCT00077675
Telavancin for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia
NCT00062647
Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)
NCT00061633
Safety and Efficacy Study of YM087 (Conivaptan) in Patients With Acute Decompensated Heart Failure
NCT00057356
Efficacy, Safety, and Pharmacokinetics of Intravenous Ibuprofen in Adult Febrile Patients
NCT01131000
Study of IV YM087 to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic Hyponatremia
NCT00380575
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 14 |
| Phase 3 | 16 |
| Phase 4 | 7 |
Therapeutic Areas
What is open in the Cumberland Pharmaceuticals pipeline
1 recruiting of 43 indexed (2% open); 37 completed (86%).
Phase mix: 23 late (III/IV) vs 19 early (I/II) (balanced across stages).
Top condition: Hyponatremia (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Cumberland Pharmaceuticals: open-pipeline peers nationwide
Peers matched on 43 registered trials and 2% open enrollment, not the therapeutic-area sidebar.
Cumberland Pharmaceuticals sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 43 trials (± recruiting share)
- Atlantic Health System · 43 trials · 16% recruiting
- Lahey Clinic · 43 trials · 9% recruiting
- Octapharma · 43 trials · 21% recruiting
- Seattle Institute for Biomedical and Clinical Research · 43 trials · 14% recruiting
Sponsors near 2% open enrollment (± trial volume)
- NSABP Foundation · 2% recruiting · 44 trials
- TriHealth · 2% recruiting · 81 trials
- Baxter Healthcare Corporation · 2% recruiting · 46 trials
- Centers for Disease Control and Prevention · 2% recruiting · 139 trials
Related
What to do with this Cumberland Pharmaceuticals page
43 registered trials is a research-attention snapshot, not an endorsement of Cumberland Pharmaceuticals or any single study.
- 1 of Cumberland Pharmaceuticals's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hyponatremia is the condition Cumberland Pharmaceuticals studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hyponatremia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Cumberland Pharmaceuticals pipeline card: 43 registered trials from official public datasets.Report a data error.